Sanofi's Attempt to Dismiss Cancer Drug Eye Injury Lawsuit Denied by Federal Judge
Sanofi-Aventis US LLC faced a legal setback as a federal judge denied their request for summary judgment in a lawsuit alleging that their chemotherapy drug, Taxotere, caused eye injuries. The case, heard in the US District Court for the Eastern District of Louisiana, involves cancer patients who claim that Taxotere and its generic version, docetaxel, led to irreversible eye damage through tear duct blockages. The plaintiffs argue that the treatment can cause nasolacrimal duct stenosis, a condition that narrows the tear ducts. Sanofi sought to exclude the plaintiffs' expert testimony, but Judge Jane Triche Milazzo only partially excluded one expert's testimony, allowing the case to proceed.